NASAL-ADMINISTERED VACCINES USING MULTI-SCREENED NALT-TARGETING AND PHAGOCYTIC POLYPEPTIDE TRANSPORT SEQUENCES
    9.
    发明申请
    NASAL-ADMINISTERED VACCINES USING MULTI-SCREENED NALT-TARGETING AND PHAGOCYTIC POLYPEPTIDE TRANSPORT SEQUENCES 审中-公开
    使用多层筛选和药代动力学运输序列的NASAL-管理疫苗

    公开(公告)号:US20100278846A1

    公开(公告)日:2010-11-04

    申请号:US12636705

    申请日:2009-12-11

    申请人: IAN A. FERGUSON

    发明人: IAN A. FERGUSON

    IPC分类号: A61K39/00 A61P37/04

    摘要: Multiple sequential screening tests have been performed on phage display libraries, and polypeptide sequences have been identified that potently drive both: (i) intake into mucosal immune cells, including NALT cells in the nose and throat; and, (ii) phagocytic intake and processing by antigen-presenting cells, such as macrophages. Such polypeptide sequences can be used as potent “target and deliver” components in vaccines that can be administered nasally, or to other mucous membranes. Such vaccines can be made very rapidly and in huge quantities, from bacteriophages that will also carry antigenic sequences in their coat proteins, or other immunoactive components. Alternately, such “target and deliver” polypeptides can be incorporated into vaccines derived from eukaryotic viruses or cellular pathogens. Enhancements also are disclosed, such as agents that can activate one or more types of toll-like receptors, to increase immunes responses and guide them in desired directions.

    摘要翻译: 已经对噬菌体展示文库进行了多次连续的筛选测试,并且已经鉴定出有效驱动两者的多肽序列:(i)摄入到粘膜免疫细胞,包括鼻和喉部的NALT细胞; 和(ii)由抗原呈递细胞如巨噬细胞吞噬摄入和加工。 这样的多肽序列可以用作可以被鼻腔或其它粘膜施用的疫苗中的有效的“靶和递送”成分。 这样的疫苗可以非常迅速地并且大量地从还会在其外壳蛋白或其它免疫活性成分中携带抗原序列的噬菌体制备。 或者,这样的“靶和递送”多肽可以并入来自真核病毒或细胞病原体的疫苗中。 还公开了增强剂,例如可以激活一种或多种类型的toll样受体的药剂,以增加免疫反应并将它们引导到期望的方向。